Article

MASLD Under the Umbrella of the Microbiota: A Narrative Review on Ecological Risk and Functional Transmissibility

2025-12-29

Abstract excerpt

Metabolic dysfunction–associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease worldwide, distinguished by pronounced clinical heterogeneity and a frequent dissociation between metabolic risk factors and the degree of hepatic injury. These observations, together with the limited contribution of genetic heritability, have prompted a re-evaluation of the traditional conceptual framewo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d94edd68-ab21-5338-ab46-c8ce75189aa6
DOI: 10.20944/preprints202512.2476.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

MASLD Under the Umbrella of the Microbiota: A Narrative Review on Ecological Risk and Functional TransmissibilityDOI 10.20944/preprints202512.2476.v1Read

Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver DiseaseSemantic proximity Read

Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinomaSemantic proximity Read

A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literatureSemantic proximity Read

Mapping the genomic landscape of MASLD: A framework for molecular subtyping and precision hepatology.Semantic proximity Read

Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liverSemantic proximity Read

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disordersSemantic proximity Read

Abnormal Gut Microbiota Metabolism Specific for Liver CirrhosisSemantic proximity Read

Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtypingSemantic proximity Read

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity Read

Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and ChallengesSemantic proximity Read

Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk.Semantic proximity Read

The Gut Microbiota and Liver DiseaseSemantic proximity Read